. 2019 Apr 24;6:85. doi: 10.3389/fmed.2019.00085

Table 2.

Univariate global Moran's indices of the prevalence of dermatomyositis (DM) and subtypes, and bivariate global Moran's indices of DM prevalence vs. 2011 NATA metrics.

Outcome variable	Lagged variable	Global Moran's index	Pseudo p-value
DM prevalence	Univariate	0.0054	0.16
	Total airborne risk^*	0.0080	0.34
	Point sources^*	0.0019	0.36
	On-road sources^*	0.0057	0.15
	Secondary sources^*	0.0036	0.46
CDM prevalence	Univariate	0.0051	0.16
	Total airborne risk^*	0.0080	0.33
	Point sources^*	−0.0053	0.46
	On-road sources^*	0.0082	0.28
	Secondary sources^*	−0.00076	0.47
CADM prevalence	Univariate	0.064	0.06
	Total airborne risk^*	−0.0015	0.49
	Point sources^*	0.071	0.02
	On-road sources^*	−0.025	0.18
	Secondary sources^*	0.043	0.09

CADM, clinically amyopathic dermatomyositis; CDM, classic dermatomyositis; DM, dermatomyositis; NATA, National Air Toxics Assessment.

Bivariate global Moran's index.

Bold values indicate significant finding.